On March 6, 2018, 23andMe, Inc. received the first-ever FDA authorization for a direct-to-consumer genetic test that analyzes gene mutations... Read More

A controversial study of the H5N1 bird flu virus has been published today in the journal Nature. The study, and... Read More

Fanconi anemia, a recessive hereditary disease, leads to dysplasia, degeneration of bone marrow, and an increased risk of leukemia and tumors.... Read More

Stage III and IV melanoma patients are routinely tested for the BRAF gene mutation, a known oncogene for melanoma. Recently,... Read More

Researchers at University of California, Los Angeles have worked with a California family stricken by an extremely rare, devastating disorder... Read More

Scientists at the University of California, San Francisco have discovered that mutations in a gene called FLT3 could hold the... Read More